Michael Snyder, PhD

Dr. Michael Snyder is the Stanford W. Ascherman Professor and Chair of the Genetics Department at Stanford Medicine. Under his leadership U.S. News & World Report has ranked Stanford University first in Genetics, Genomics, and Bioinformatics every year for the past decade. As the leading pioneer of 21st century healthcare, Dr. Snyder invented and significantly advanced many industry-standard approaches to personalized medicine. Most recently his research involving longitudinal baseline profiling and state-of-the-art “omic” technologies research has greatly accelerated the advancement of precision medicine. As an entrepreneur, Dr. Snyder’s co-founded companies are worth more than $6 billion in value.

Ariel Ganz, PhD

Ariel Ganz applies her PhD in nutrition from Cornell to her research at Stanford on precision mental health and well-being. Working with Precision Medicine Pioneer Dr. Michael Snyder, Ariel is at the forefront of applying multi-omics to clinical mental health research. Ariel is a founding partner at Arben Ventures, championing early-stage startups at the cutting edge of deep-tech health and wellness. Ariel is deeply committed to amplifying interdisciplinary connection, and transformative ideas in mental health.

Ziv Lautman

Ziv Lautman is pursuing a Ph.D. in Bioengineering at Stanford University under the mentorship of Dr. Michael Snyder. Having been awarded the William K. Bowes Jr. Stanford Graduate Fellowship, he leads a large-scale study on the use of wearable devices for the early detection and treatment of mental health conditions. Ziv’s thesis work is emphasizing precision medicine’s role in enhancing health-span, life-span, and overall well-being. Before his time at Stanford, Ziv co-founded and led a digital environmental-health company that was acquired by Google.